Work

Combination checkpoint immunotherapy and cytotoxic chemotherapy: Pembrolizumab (Pembro) plus either docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.398

Authors: Primo Lara, Laurel Beckett, Yueju Li, Mamta Parikh, Daniel Robles, Pawandeep Aujla, Chong-xian Pan

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597542073

Cites:

Cited by: 14

Related to: 10